Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

symptoms

- PMLiVE

Safe from harm?

Which healthcare systems inspire patient confidence?

- PMLiVE

Who’s listening? Why a tailored approach to education improves outcomes

In an increasingly resource-constrained environment with a growing need to show measurable impact in patient outcomes, medical education needs to smarten up. A blanket approach is no longer enough: we...

- PMLiVE

Thornton & Ross Dermatology launches eczema consultation tool

Aims to help HCPs identify and tackle the impact of the skin condition

- PMLiVE

Biogen launches Remicade biosimilar in the UK

Flixabi provides another low-cost alternative to J&J’s biggest-selling drug

- PMLiVE

Portrait exhibition raises refugee healthcare profile

Doctors of the World opens gallery to mark 10-year anniversary of its London clinic

- PMLiVE

SO What Global launches patient engagement venture

New agency will focus on aiding pharma companies’ pursuit of patient-centricity

Novartis day

Novartis claims first place for its biosimilar Enbrel in US

However, Amgen’s patent infringement lawsuit could delay the launch of Erelzi

- PMLiVE

Multichannel: the essential European revolution

Boosting the digital component in Europe's multichannel engagement strategy

- PMLiVE

Drug of choice

Can patients make the right decisions?

- PMLiVE

Defining value: has anyone asked the patient?

The real-world challenges patients face give them unique views on ‘value’

- PMLiVE

Gilead launches European hep C awareness drive

Aims to highlight significance of cure through patient storytelling initiative

- PMLiVE

Making a difference with medical education

Curiosity drives us, tenacity allows us to rise and creativity enables us to shine

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links